Security key
74017N105
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 136,011,489
- Total 13F value
- $568,542,925
- Share change
- +22,261,196
- Put/Call ratio
- 2.7%
- SEC-reported price per share
- $4.18
- Number of holders
- 179
- Value change
- +$96,374,703
- Number of buys
- 107
- Number of sells
- 51
- Shares outstanding
- 353,007,843
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
179
Top holders
10
PGEN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
PRECIGEN, INC. SEC filings
PRECIGEN, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74017N105
Recent filing periods:
Ownership snapshot
Top reported holders of PGEN - PRECIGEN, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Patient Capital Managemen...
Disclosed value leader
William H. Miller III
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 10%
13D/G row: Patient Capital Management, LLC
Showing 1-6 of 15 holder rows.
Quick read
Patient Capital Management, LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Patient Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
Patient Capital Management, LLC
10%
William H. Miller III
9.2%
TANG CAPITAL MANAGEMENT LLC
3.5%
BlackRock, Inc.
3.4%
VANGUARD GROUP INC
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Patient Capital Management, LLC |
13D/G
13F
Company
|
10%
|
$150,508,424
36,006,800 shares
|
-$38,525,651 | 31 Dec 2025 |
| William H. Miller III |
13D/G
William H. Miller III Living Trust dated April 17, 2017
|
9.2%
|
$154,936,259
34,051,925 shares
|
$0 | 26 Jun 2025 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
3.5%
|
$40,796,000
12,400,000 shares
|
— | 30 Sep 2025 |
| BlackRock, Inc. |
13F
Company
|
3.4%
|
$39,973,352
12,149,955 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
2.5%
|
$29,420,118
8,942,285 shares
|
— | 30 Sep 2025 |
| STATE STREET CORP |
13F
Company
|
1.3%
|
$14,771,531
4,489,827 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
179
Shares
136,011,489
Rows available
179
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
165
Q4 2025 holders
179
Holder diff
14
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend